SOUTH SAN FRANCISCO, Calif., Oct. 14, 2015 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc., (Nasdaq:ATRA), today announced that the Company will host a live webcast in conjunction with its Investor Day on Wednesday, October 21, 2015 at 12:00p.m. ET in New York, NY.
The live audio webcast and the accompanying slide presentations can be accessed through the Events & Presentations section of the Company's website at investors.atarabio.com. A replay of the webcast will be available on the Company's website for two weeks following the event.
About Atara Biotherapeutics, Inc.
Atara Biotherapeutics, Inc. is a biopharmaceutical company focused on developing innovative therapies for patients with debilitating diseases. Atara Bio’s programs include molecularly targeted product candidates and T-cell product candidates. Molecularly targeted product candidates include PINTA 745, STM 434 and ATA 842. These product candidates target myostatin and activin, members of the TGF-beta family of proteins, and have demonstrated the potential to have therapeutic benefit in a number of clinical indications. T-cell product candidates include EBV-CTL, CMV-CTL and WT1-CTL.
Investor & Media Contact: Tina Gullotta Atara Biotherapeutics, Inc. 650-741-1613 email@example.com For Investor Day Inquiries: John Grimaldi Burns McClellan 212-213-0006, ext. 362 firstname.lastname@example.org
Source:Atara Biotherapeutics, Inc.